Overview: Explains in-depth lyophilized (or dehydrated) formulation strategies considering diverse modalities of biologics and vaccines, including plasmid DNA and lipid-based therapeutics.Provides recent unders.This book provides a detailed account of the most recent developments, challenges and solutions to seamlessly advance and launch a lyophilized biologics or vaccine product, based on diverse modalities, ranging from antibodies (e.g., .monoclonal, fused.), complex biologics (e.g., .antibody drug conjugate, PEGylated proteins.), and vaccines (e.g., .recombinant-protein based.). The authors
|